Abstract
The effectiveness of Levamisole combined with Mitomycin-C, FT-207 and PS-K for treating gastric cancer was investigated in a prospective randomized controlled study. All patients had undergone gastrectomy during the years from August 1977 to November 1980. Five year survival rates reveled no difference between groups given or not given Levamisole. In those with positive lymphode metastases plus obvious serosal invasion, there was a significant elevation in the survival rate at four years after gastrectomy. The effectiveness of Levamisole was confirmed by postoperative changes in the PPD skin test, lymphocyte blastogenesis to PHA and serum inhibition index.
Similar content being viewed by others
References
Renoux, G. and Renoux, M.: Effect immunostimulant d'un imidothiazole dans l'immunisation des souris contre l'infection par Brucells abortus. C.R. Acad. Sci. (D), 272: 349 1971.
Toge, T., Ikeda, H., Senou, N., Niimoto, M. and Hattori, T.: Leucocyte responsiveness to phytohemagglutinin (PHA) and serum inhibitory effect in patients with gastric cancer. Jpn. J. Surg. 7: 157–163, 1976.
Japanese Research Society for Gastric Cancer: The general rules for gastric cancer study in surgery and pathology. Jpn. J. Surg. 11: 127–129, 1981.
Cutler, S. J. and Ederer, F.: Maximum utilization of the life table method in analyzing survival. J. Chron. Dis. 8: 699–712, 1958.
Gehan, E.: A generalized Wilcoxon test for comparing arbitrarily single-censored samples. Biometrika, 52: 203–224, 1965.
Fujimoto, S., Akao, T., Itoh, B., Koshizuka, I., Koyano, K., Kitsukawa, Y., Takahashi, M., Minami, T., Ishigami, H., Kure, M., Itoh, K. and Hirosaki, T.: Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer. Ann. Surg. 185: 462–466, 1977.
Kano, T., Kumashiro, R., Masuda, H., Okamura, T. and Inokuchi, K.: Late results of postoperative long-term cancer chemotherapy for the gastric cancer patients subjected to curative resection. Jpn. J. Surg. 13: 112–116, 1983.
Inokuchi, K., Hattori, T., Taguchi, T., Abe, O. and Ogawa, N.: Postoperative adjuvant chemotherapy for gastric cancer—Analysis of data on 1,805 patients followed for 5 years. Cancer (in press).
Amery, W. K.: Final results of a multicenter placebo-controlled levamisole study of resectable lung cancer. Cancer Treat. Rep., 62: 1677–1683, 1978.
Hall, S. W., Benjamin, R. S., Lewinski, U. and Mavligit, G.: Actinomycin-D, Levamisole immunochemotherapy of refractory malignant melanoma. Cancer, 43: 1195–1200, 1979.
Rojas, A. F., Micklewicz, E., Feierstein, J. N., Glait, H. and Olivari, A. J.: Levamisole in advanced human breast cancer. Lancet, II: 211–215, 1976.
Borden, E. C., Davis, T. E., Crowley, J. J., Wolberg, W. H., NcKnight, B. and Chirigos, M. A.: Interim analysis of a trial of levamisole and 5-fluorouracil in metastatic colorectal carcinoma. 2nd International Conference on Immunotherapy of Cancer. Bethesda, 1980.
Wanebo, H., Hilai, E. Y., Pinsky, C. M., Strong, E. W., Mike, V., Hirshaut, Y. and Oettgen, H. F.: Randomized trial of levamisole in patients with squamous cell cancer of the head and neck. Cancer Treat. Rep., 62: 1663–1669, 1978.
Hattori, T., Niimoto, M., Koh, T., Nakano, A., Oride, M., Takiyama, W. and Nishimawari, K.: Postoperative long-term adjuvant immunochemotherapy with mitomycin-C, PS-K and FT-207 in gastric cancer patients. Jpn. J. Surg., 9: 110–117, 1979.
Hattori, T., Niimoto, M., Oride, M., Inokuchi, K. and Taguchi, T.: Postoperative chemotherapy with futraful and mitomycin-C and chemoimmunotherapy in gastric cancer. Beitrage zur Onkologie 14: 103–117, Karger, Basel, 1983.
Niimoto, M., Hattori, T., Orita, K., Furue, H., Ogawa, N., Tamada, R. and Inokuchi, K.: Effect of levamisole in adjuvant chemotherapy of resectable gastric cancer. A preliminary report. 13th International Cancer Congress, Seattle, 1982.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hattori, T., Niimoto, M., Toge, T. et al. Effects of levamisole in adjuvant immunochemotherapy for gastric cancer; A prospective randomized controlled study. The Japanese Journal of Surgery 13, 480–485 (1983). https://doi.org/10.1007/BF02469490
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02469490